巴菲特致信股東稱患前列腺癌遠不危及生命 7月中放療

股神巴菲特(資料圖)
北京時間4月18日上午消息,股神巴菲特確診患前列腺癌,以下為巴菲特致伯克希爾-哈撒韋股東信。
伯克希爾-哈撒韋股東:
本信是告知各位我已被診斷患一期前列腺癌癥。好消息是醫生告知我的病情遠不危及生命,甚至不會顯著影響身體機能。上周三我接受了診斷,周四做了CAT掃描和骨掃描,本周三做了核磁共振。這些檢查均未顯示身體其余部分患癌。
醫生和我本人決定,從7月中旬開始進行為期兩個月的每日放療。在此期間我的出行將受到限制,但日常工作不會發生變化。
我感覺良好——仿佛處于正常的良好健康狀態中——我的精力十分充沛。我發現自己患癌,是因為前列腺特異性抗原(PSA)水平近來大超正常水平,活檢似乎得到確認。
要是病情發生變化,我將立刻通知各位股東。當然,最終那一天將到來,但我相信離那一天還很遠。
附:巴菲特致伯克希爾-哈撒韋股東信,英文原文
FOR IMMEDIATE RELEASE April 17, 2012
Omaha, NE (BRK.A; BRK.B) –
To the Shareholders of Berkshire Hathaway:
This is to let you know that I have been diagnosed with stage I prostate cancer. The good news is that I’ve been told by my doctors that my condition is not remotely lifethreatening or even debilitating in any meaningful way. I received my diagnosis last Wednesday. I then had a CAT scan and a bone scan on Thursday, followed by an MRI today. These tests showed no incidence of cancer elsewhere in my body。
My doctors and I have decided on a two-month treatment of daily radiation to begin in mid-July. This regimen will restrict my travel during that period, but will not otherwise change my daily routine。
I feel great – as if I were in my normal excellent health – and my energy level is 100 percent. I discovered the cancer because my PSA level (an indicator my doctors had regularly checked for many years) recently jumped beyond its normal elevation and a biopsy seemed warranted。
I will let shareholders know immediately should my health situation change. Eventually,of course, it will; but I believe that day is a long way off。
巴菲特患前列腺癌:
巴菲特規則:
巴菲特傳奇:
巴菲特與中國:
【獨家稿件聲明】凡注明“鳳凰財經”來源之作品(文字、圖片、圖表或音視頻),未經授權,任何媒體和個人不得全部或者部分轉載。如需轉載,請與鳳凰網財經頻道(010-84458352)聯系;經許可后轉載務必請注明出處,違者本網將依法追究。
- 社會
- 娛樂
- 生活
- 探索
湖北一男子持刀拒捕捅傷多人被擊斃
04/21 07:02
04/21 07:02
04/21 07:02
04/21 06:49
04/21 11:28
頻道推薦
商訊
- 單日流入資金最多個股
- 明星分析師薦股
48小時點擊排行
-
2052232
1杭州某樓盤一夜每平大降數千元 老業主 -
992987
2杭州某樓盤一夜每平大降數千元 老業主 -
809366
3期《中國經營報》[ -
404290
4外媒關注劉漢涉黑案:由中共高層下令展 -
287058
5山東青島住戶不滿強拆掛橫幅抗議 -
284796
6實拍“史上最爽職業”的一天(圖) -
175136
7媒體稱冀文林將石油等系統串成網 最后 -
156453
8養老保險制度如何“更加公平可持續”
















